Refine by
Briacell Clinical Developments Equipment & Supplies
2 equipment items found
Manufactured by:BriaCell Therapeutics Corp. based inWest Vancouver, BRITISH COLUMBIA (CANADA)
PKCδ also has potential activity as an immunotherapeutic by blocking TGFβ signaling. PKCδ inhibitors are applicable to specific niche tumor types which provide an accelerated clinical development plan. Could be in clinic within 24 months. Provides Cost-Effective Additional Shot-on-Goal and additional partnership ...
Manufactured by:BriaCell Therapeutics Corp. based inWest Vancouver, BRITISH COLUMBIA (CANADA)
We believe our cellular immunotherapy is most effective when the patient’s HLA-type matches the Bria-IMT™ HLA-type. We are engineering 15 unique HLA types (molecules) into Bria-IMT™, collectively referred to as Bria-OTS™, allowing for matching of over 99% of patients with advanced breast cancer. A simple saliva test is used to determine the HLA-type of each ...